Comparision between phenobarbitone and levetiracetam as the intial anti convulsant in treating preterm neonatal seizures
Phase 4
- Conditions
- Health Condition 1: P90- Convulsions of newborn
- Registration Number
- CTRI/2021/02/031290
- Lead Sponsor
- Gummalla Gyandeep
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Neonate with gestational age <37 week with diagnosis of clinical seizure admitted within 28 days of life in NICU
Exclusion Criteria
Multiple congenital malformation, Seizure secondary to hypoglycemia and hypocalcemia controlled with glucose or calcium bolus respectively
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Cessation of seizure in first 24 hours of seizureTimepoint: 24 hours
- Secondary Outcome Measures
Name Time Method Clinical response based on the etiology of seizure.Timepoint: 1 month